Doshi S K, Negus I S, Oduko J M
Medical Physic and Bioengineering, UBHT, Bristol General Hospital, Guinea Street, Bristol BS1 6SY, UK.
Br J Radiol. 2008 Aug;81(968):653-8. doi: 10.1259/bjr/22775594. Epub 2008 Apr 14.
Pulmonary embolism (PE) is the leading direct cause of maternal mortality in the UK. Accurate diagnosis is important but, even though CT pulmonary angiography (CTPA) is the recommended imaging modality for PE in the general population, there is limited guidance for pregnant patients. Knowledge of the radiation doses to both the mother and the fetus is therefore important in the justification of CTPA in this situation. Dose measurements were made on three helical CT scanners, with an anthropomorphic phantom representing the chest and abdomen in late gestation. Estimated fetal doses from CT scans of the maternal chest were in the range of 60-230 microGy. Fetal dose reduction strategies (mA modulation, shielding with a lead coat, and a 5 cm shorter scan length) were investigated. These reduced the fetal dose by 10%, 35% and 56%, respectively. Fetal doses from a scan projection radiograph (SPR) of the maternal chest were insignificant when compared with the dose from a CT scan. However, if the SPR was not stopped before the "fetus" was directly irradiated, the dose measured on one scanner was 20 microGy.
肺栓塞(PE)是英国孕产妇死亡的主要直接原因。准确诊断很重要,然而,尽管CT肺动脉造影(CTPA)是一般人群中推荐用于PE的成像方式,但针对孕妇的指导有限。因此,了解母亲和胎儿所接受的辐射剂量对于在这种情况下使用CTPA的合理性很重要。在三台螺旋CT扫描仪上进行了剂量测量,使用一个模拟妊娠晚期胸部和腹部的人体模型。对母亲胸部进行CT扫描时,估计胎儿所接受的剂量在60 - 230微戈瑞范围内。研究了胎儿剂量降低策略(毫安调制、用铅衣屏蔽以及扫描长度缩短5厘米)。这些策略分别使胎儿剂量降低了10%、35%和56%。与CT扫描的剂量相比,母亲胸部的扫描投影射线照片(SPR)对胎儿的剂量微不足道。然而,如果在“胎儿”直接受到照射之前不停止SPR,在一台扫描仪上测得的剂量为20微戈瑞。